In Brief: Somatix Therapy
Executive Summary
Somatix Therapy: Bristol-Myers Squibb to make second $10 mil. equity investment in company following clearance for Phase III trials of Somatix' GVAX cancer vaccine. Bristol made the first investment of $10 mil. in August and expects to close the second by the end of April...